Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
B. Riley Financial Granted Extension From Nasdaq Regarding Listing Rules
10:00am, Friday, 06'th Jun 2025
Announces Notification of Additional Delinquency with Nasdaq for Late Filing of Annual Report on Form 10-K for the period ended December 31, 2024 and its Quarterly Report on Form 10-Q for the period e
Classover Approved for Options Trading
08:30am, Friday, 06'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Classover Holdings, Inc. (Nasdaq:KIDZ)(Nasdaq:KIDZW) ("Classover" or the "Company"), a leading provider of live, interactive online learning, today anno
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 06'th Jun 2025
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, tod
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 06'th Jun 2025
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-b
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Friday, 06'th Jun 2025
SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicine
Codere Online Regains Compliance with Nasdaq Listing Requirements
06:00am, Friday, 06'th Jun 2025
Luxembourg, Grand Duchy of Luxembourg, June 6, 2025 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”), a leading online gaming opera
Kyivstar Group Reaches Nasdaq Listing Milestone with Public Filing of Registration Statement on Form F-4
05:20pm, Thursday, 05'th Jun 2025
KYIV, Ukraine, June 05, 2025 (GLOBE NEWSWIRE) -- Kyivstar Group Ltd., Ukraine's leading digital operator (“Kyivstar Group” or “the Company”) and a subsidiary of VEON Ltd. (Nasdaq: VEON) (“VE
Kyivstar Group Reports First Quarter 2025 Financial Results in Conjunction with its Nasdaq Listing Process
05:20pm, Thursday, 05'th Jun 2025
KYIV, Ukraine, June 05, 2025 (GLOBE NEWSWIRE) -- Kyivstar Group, Ukraine's leading digital operator (“Kyivstar Group” or “the Company”) and a subsidiary of VEON Ltd. (Nasdaq: VEON) (“VEON Gr
Kyivstar Group Reports First Quarter 2025 Financial Results in Conjunction with its Nasdaq Listing Process
05:00pm, Thursday, 05'th Jun 2025
KYIV, Ukraine, June 5, 2025 – Kyivstar Group, Ukraine's leading digital operator (“Kyivstar Group” or “the Company”) and a subsidiary of VEON Ltd. (Nasdaq: VEON) (“VEON Group” or “VEON
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Thursday, 05'th Jun 2025
BEDFORD, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early inte
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Thursday, 05'th Jun 2025
REDWOOD CITY, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Thursday, 05'th Jun 2025
CAMBRIDGE, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based thera
3 Upcoming Dividend Increases
10:25am, Thursday, 05'th Jun 2025
I focus on companies with a strong track record of dividend growth, using data from Dividend Champions and NASDAQ to identify reliable opportunities. This week's highlighted stocks average a 7.3% divi
Columbus Circle Capital Corp I Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 9, 2025
10:15am, Thursday, 05'th Jun 2025
New York, NY, June 05, 2025 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp I (Nasdaq: CCCMU) (the “Company”) announced today that, commencing June 9, 2025, holders of the units sold in the Comp
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
09:00am, Thursday, 05'th Jun 2025
FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for
